HCM
CVS icon

Hillman Capital Management’s CVS Health CVS Stock Holding History

Hillman Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.85M Sell
67,462
-4,223
-6% -$325K 3.36% 8
2025
Q4 		$5.69M Sell
71,685
-10,674
-13% -$841K 3.58% 4
2025
Q3 		$6.21M Sell
82,359
-10,638
-11% -$729K 3.61% 4
2025
Q2 		$6.41M Sell
92,997
-7,453
-7% -$489K 3.5% 7
2025
Q1 		$6.81M Sell
100,450
-19,186
-16% -$1.15M 3.35% 3
2024
Q4 		$5.37M Sell
119,636
-1,891
-2% -$106K 1.99% 31
2024
Q3 		$7.64M Sell
121,527
-2,802
-2% -$163K 2.62% 17
2024
Q2 		$7.34M Buy
124,329
+10,291
+9% +$644K 2.59% 18
2024
Q1 		$9.1M Buy
114,038
+376
+0.3% +$28.7K 2.92% 11
2023
Q4 		$8.97M Buy
113,662
+1,354
+1% +$96.4K 3.1% 7
2023
Q3 		$7.84M Buy
112,308
+16,613
+17% +$1.18M 3.02% 13
2023
Q2 		$6.62M Sell
95,695
-652
-0.7% -$46.4K 2.34% 26
2023
Q1 		$7.16M Buy
96,347
+712
+0.7% +$59.7K 2.71% 21
2022
Q4 		$8.91M Sell
95,635
-707
-0.7% -$68.2K 3.5% 5
2022
Q3 		$9.19M Sell
96,342
-968
-1% -$95.8K 3.81% 1
2022
Q2 		$9.02M Sell
97,310
-173
-0.2% -$16.9K 3.28% 7
2022
Q1 		$9.87M Sell
97,483
-11,615
-11% -$1.22M 3.13% 6
2021
Q4 		$11.3M Sell
109,098
-3,743
-3% -$346K 3.87% 2
2021
Q3 		$9.58M Buy
112,841
+3,912
+4% +$328K 3.36% 8
2021
Q2 		$9.09M Buy
108,929
+710
+0.7% +$58.1K 3.46% 10
2021
Q1 		$8.14M Buy
108,219
+13,954
+15% +$1.02M 3.57% 7
2020
Q4 		$6.44M Buy
94,265
+13,169
+16% +$857K 3.48% 8
2020
Q3 		$4.74M Buy
81,096
+10,158
+14% +$632K 3.33% 13
2020
Q2 		$4.61M Buy
70,938
+18
+0% +$1.13K 3.36% 12
2020
Q1 		$4.21M Sell
70,920
-286
-0.4% -$19.1K 4.03% 7
2019
Q4 		$5.29M Buy
+71,206
New +$5M 3.75% 6

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hillman Capital Management's CVS Position: Q1 2026 in Review

Hillman Capital Management reduced its CVS Health (CVS) stake by 5.9% in Q1 2026, selling an estimated $325K and leaving 67,462 shares worth $4.85M. The position accounts for 3.36% of the portfolio, ranked #8.

Hillman Capital Management first reported a position in CVS in Q4 2019 and has held it in 26 quarters since. The position peaked at $11.3M in Q4 2021. 1,874 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Hillman Capital Management held 67,462 shares of CVS Health worth $4.85M as of Q1 2026.
  • Hillman Capital Management sold 4,223 CVS Health shares in Q1 2026, an estimated $325K.
  • CVS Health made up 3.36% of Hillman Capital Management's portfolio in Q1 2026, its #8 holding.
  • Hillman Capital Management first reported a position in CVS Health in Q4 2019 and has held it in 26 quarters since.
  • Hillman Capital Management's CVS Health position peaked at $11.3M in Q4 2021.
  • 1,874 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Hillman Capital Management's 13F filing for Q1 2026, filed 15 May 2026.